IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway [Retraction]
Zhou X, Feng Y, Liu S, et al. Cancer Manag Res. 2021;13:2379–2388. We, the Editors and Publisher of Cancer Management and Research, have retracted the published article. Concerns were raised following the authors request to make changes to Figures 1 and 2 after finding some images had bee...
Main Authors: | Zhou X, Feng Y, Liu S, Li C, Teng Y, Li X, Lu J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-08-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/retraction-il-33-promotes-the-growth-of-non-small-cell-lung-cancer-cel-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
by: Danxia Cao, et al.
Published: (2020-09-01) -
Role of ELK1 in regulating colorectal cancer progression: miR-31-5p/CDIP1 axis in CRC pathogenesis
by: Guoqiang Yan, et al.
Published: (2023-07-01) -
MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer
by: Qingan Jia, et al.
Published: (2023-12-01) -
The Role of miR-128 in Neurodegenerative Diseases
by: Marika Lanza, et al.
Published: (2023-03-01) -
The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy
by: Hendrik Setia Budi, et al.
Published: (2023-01-01)